- Start
- Controlling Pharmaceutical Risks
Controlling Pharmaceutical Risks
Angebote / Angebote:
Controlling Pharmaceutical Risks analyses changes in drug testing since the late 1990s, specifically geneticization of carcinogenic risk assessment and regulation of pharmaceuticals, involving issues fundamental to bio-science, medical treatment and patients¿ health, such as what knowledge is judged necessary to determine carcinogenic risk to humans, and how that judgement transpired.
Noch nicht erschienen. Termin unbekannt
